Not exact matches
By studying how these genes cause defects in fly and mouse
models, we can
improve our insights into the mechanisms related to
human disease,» said corresponding author and Dr. Hugo J. Bellen, professor
of neuroscience and molecular and
human genetics at Baylor College
of Medicine and an investigator at the Howard Hughes Medical Institute.
Combining chemotherapy and birinapant significantly
improved disease - free survival in laboratory
models of human ovarian cancer compared to using either therapy alone.
«If the mouse
models are indicative
of human disease, the combination therapy can increase the proportion
of patients who respond to therapy without additional adverse side effects and can
improve the quality
of life for cancer patients.»
«We think that by restoring the natural «microbial identity»
of laboratory mice, we will
improve the
modeling of complex
diseases of free - living mammals, which includes
humans and their
diseases,» said Barbara Rehermann, M.D., senior author
of the paper.
FOA encourages research grant applications from institutions / organizations that propose to develop, characterize or
improve animal
models for
human disease or to
improve diagnosis and control
of diseases that might interfere with animal use for biomedical research purposes.
Clinicians and investigators in the fields
of veterinary and
human endocrine oncology, clinical trials, pathology, and drug development will be joined in this consortium, in order to
improve knowledge, development
of, and access to naturally occurring canine endocrine tumours, as a
model for
human disease.
These experiments are innovative because they seek to
improve a mouse
model based on current knowledge from
human disease, while also testing novel therapies that could be
of benefit for affected individuals.
These mouse
models are useful tools to
improve our understanding
of the biological significance and functional relevance
of these polymorphisms in
human disease, particularly when validated with controlled exposures and environmental challenges.
Technology utilizing
human induced pluripotent stem cells (iPS cells) has enormous potential to provide
improved cellular
models of human disease.
In rodents, ketogenic diets reduce reactive oxygen species in the brain34 and reduce central inflammation and reactive oxygen species in a
model of multiple sclerosis.35 Two clinical papers have found that ketogenic diet feeding
of 12 weeks to 6 months reduced signs
of liver inflammation in obese patients with nonalcoholic fatty liver
disease (in addition to
improving various other physiological and biochemical variables).36, 37 Unfortunately, basic research into non-alcoholic fatty liver
disease has been hampered by species differences between mice and
humans in their hepatic reaction to ketogenic diets.38
Animal
models are necessary to develop
improved diagnostics and therapeutics, as well as understanding the basic pathophysiology
of common
human laryngeal
diseases.
This
model is important in that it addresses a significant
disease and can
model how to identify and change
human variables to better
improve other aspects
of the complex relationships that we have with domestic and companion animals.